Revenio Group’s Q2 2026 Collapse: Margin Squeeze Drives 18% Share DropRevenio Group’s Q2 2026 earnings miss sparks an 18% share slide as margin compression and Visionix integration woes erode investor confidence.REVENIO GROUP OYJ Health Care Health Care Equipment & Services AI generated 10/09/2026, 08:23 3 minutes to read
Revenio Group Oyj to Acquire Visionix International, Targeting €290 M Deal & 2029 EBITDA BoostRevenio Group Oyj’s €250 m Visionix acquisition aims to become a turnkey eye‑care leader, doubling its TAM, boosting EBITDA and expanding OCT expertise by Q2 2026.REVENIO GROUP OYJ Health Care Health Care Equipment & Services AI generated 13/04/2026, 08:47 3 minutes to read